Challenges for nurses and the advantages of The Career and Education Framework
Susanne Cruickshank et al.
Trial results of vemurafenib, cobimetinib and LDH as a predictive marker in BRAF-mutated melanoma
Facing end-of-life decisions as a clinical team
The importance of biomarkers to optimize treatment with immunotherapy for melanoma
Developments in the genetic testing of melanoma in clinical practice
Maria Concetta Fargnoli